|
DE2847693A1
(de)
*
|
1978-11-03 |
1980-05-22 |
Hoechst Ag |
Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
|
|
US4814335A
(en)
*
|
1982-12-30 |
1989-03-21 |
Biomeasure, Incorporated |
Antiviral compounds
|
|
US4625026A
(en)
*
|
1982-12-30 |
1986-11-25 |
Biomeasure, Inc. |
2-amino-4-oxo-tricyclicpyrimidines having antiviral activities against herpes simplex virus type II infections
|
|
JPS6442472A
(en)
*
|
1987-08-10 |
1989-02-14 |
Kanebo Ltd |
Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
|
|
US4877790A
(en)
*
|
1987-12-15 |
1989-10-31 |
Kanebo Limited |
Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
|
|
TW334434B
(en)
*
|
1995-05-16 |
1998-06-21 |
Kanebo Ltd |
Novel quinazoline compound and anti-tumor agent
|
|
WO1997042192A1
(de)
*
|
1996-05-07 |
1997-11-13 |
Basf Aktiengesellschaft |
Imidazo-chinazoline, sie enthaltende mittel und deren verwendung zur bekämpfung von schadpilzen und tierischen schädlingen
|
|
US6900220B2
(en)
|
2001-01-02 |
2005-05-31 |
Syntex (U.S.A.) Llc |
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
|
|
JP4031363B2
(ja)
*
|
2001-01-02 |
2008-01-09 |
エフ．ホフマン−ラ ロシュ アーゲー |
α−１Ａ／Ｂアドレナリン作動性受容体拮抗薬としてのキナゾロン誘導体
|
|
CN1209392C
(zh)
*
|
2001-05-14 |
2005-07-06 |
阿姆诺洼化学有限公司 |
由含侧氟碳基的环状单体得到的聚合物表面活性剂
|
|
EP1407774A1
(en)
*
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
EP1398032A1
(en)
*
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
ATE552252T1
(de)
|
2002-10-01 |
2012-04-15 |
Mitsubishi Tanabe Pharma Corp |
Isochinolinverbindungen und deren medizinische verwendung
|
|
WO2004048339A1
(ja)
|
2002-11-22 |
2004-06-10 |
Mitsubishi Pharma Corporation |
イソキノリン化合物及びその医薬用途
|
|
CA2546002C
(en)
|
2003-11-20 |
2012-09-18 |
Janssen Pharmaceutica N.V. |
7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
|
EA009875B1
(ru)
|
2003-11-20 |
2008-04-28 |
Янссен Фармацевтика Н.В. |
6-алкенил и 6-фенилалкил замещенные 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы
|
|
UA88012C2
(uk)
|
2004-06-30 |
2009-09-10 |
Янссен Фармацевтика Н.В. |
Похідні хіназоліндіону як інгібітори parp
|
|
CA2568835C
(en)
|
2004-06-30 |
2014-05-27 |
Janssen Pharmaceutica N.V. |
Quinazolinone derivatives as parp inhibitors
|
|
MXPA06014542A
(es)
|
2004-06-30 |
2007-03-23 |
Janssen Pharmaceutica Nv |
Derivados de ftalazina como inhibidores de poli(adp-ribosa) polimerasa-i.
|
|
US8003790B2
(en)
*
|
2005-02-18 |
2011-08-23 |
Mitsubishi Tanabe Pharma Corporation |
Salt of proline derivative, solvate thereof, and production method thereof
|
|
TWI400234B
(zh)
|
2006-03-31 |
2013-07-01 |
Janssen Pharmaceutica Nv |
作為組織胺ｈ4受體調節劑之苯并咪唑-２-基嘧啶類及吡類
|
|
US8299256B2
(en)
|
2007-03-08 |
2012-10-30 |
Janssen Pharmaceutica Nv |
Quinolinone derivatives as PARP and TANK inhibitors
|
|
ES2448870T3
(es)
|
2007-10-26 |
2014-03-17 |
Janssen Pharmaceutica, N.V. |
Derivados de quinolina como inhibidores de PARP
|
|
EP2271626B1
(en)
|
2008-03-27 |
2014-11-26 |
Janssen Pharmaceutica, N.V. |
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
|
|
US8168644B2
(en)
|
2008-03-27 |
2012-05-01 |
Janssen Pharmaceutica Nv |
Quinazolinone derivatives as tubulin polymerization inhibitors
|
|
PE20140592A1
(es)
*
|
2008-06-30 |
2014-05-16 |
Janssen Pharmaceutica Nv |
Proceso para la preparacion de derivados de benzoimidazol-2-il pirimidina
|
|
US9371311B2
(en)
|
2008-06-30 |
2016-06-21 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyrimidine derivatives
|
|
BRPI0922224A2
(pt)
|
2008-12-08 |
2016-08-02 |
Vm Pharma Llc |
composições de inibidores de proteína tirosina quiinase receptora.
|
|
US8987444B2
(en)
*
|
2010-01-18 |
2015-03-24 |
Msn Laboratories Private Limited |
Process for the preparation of amide intermediates and their use thereof
|
|
WO2012131706A1
(en)
*
|
2011-03-20 |
2012-10-04 |
Cadila Healthcare Limited |
Amorphous form of vilazodone hydrochloride and process for its preparation
|
|
DE102011113749A1
(de)
*
|
2011-09-14 |
2013-03-14 |
Aicuris Gmbh & Co. Kg |
Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
|
|
KR20140072897A
(ko)
*
|
2011-09-30 |
2014-06-13 |
얀센 파마슈티카 엔.브이. |
（１－（４－플루오로페닐）－１ｈ－인돌－５－일）－（３－（４－（티아졸－2－카르보닐）피페라진－１－일）아제티딘－１－일）메탄온의 결정성 하이드로클로라이드 염，및 통증 및 대사 장애의 치료에 있어서의 이의 용도
|
|
MY169233A
(en)
|
2012-03-15 |
2019-03-19 |
Celgene Car Llc |
Solid forms of an epidermal growth factor receptor kinase inhibitor
|
|
CN109053595B
(zh)
|
2012-03-15 |
2022-04-01 |
西建卡尔有限责任公司 |
表皮生长因子受体激酶抑制剂的盐
|
|
US20130261134A1
(en)
*
|
2012-03-30 |
2013-10-03 |
Boehringer Ingelheim International Gmbh |
Mesylate salt forms of a potent hcv inhibitor
|
|
EA201591051A1
(ru)
|
2013-02-08 |
2016-06-30 |
Селджен Авиломикс Рисерч, Инк. |
Ингибиторы erk и варианты их применения
|
|
SI2964229T1
(sl)
|
2013-03-06 |
2020-02-28 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-il pirimidin modulatorji receptorja histamina H4
|
|
US8999992B2
(en)
|
2013-03-15 |
2015-04-07 |
Vm Pharma Llc |
Crystalline forms of tryosine kinase inhibitors and their salts
|
|
US10053452B2
(en)
*
|
2013-12-03 |
2018-08-21 |
Amgen Inc. |
Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine salts and uses thereof
|
|
WO2016025561A1
(en)
|
2014-08-13 |
2016-02-18 |
Celgene Avilomics Research, Inc. |
Forms and compositions of an erk inhibitor
|
|
AU2015318324A1
(en)
|
2014-09-17 |
2017-04-06 |
Mundipharma International Corporation Limited |
Crystalline forms of tyrosine kinase inhibitors and their salts
|
|
WO2017161937A1
(zh)
*
|
2016-03-22 |
2017-09-28 |
江苏豪森药业集团有限公司 |
Egfr抑制剂游离碱或其酸式盐的多晶型、其制备方法和应用
|